David Camp

Cordis Corp. develops and manufactures devices for interventional vascular medicine and electrophysiology. The firm's products include guidewires, balloons, forceps, catheters, and stents to treat a variety of circulatory system problems including coronary artery disease and cerebral aneurysms. The company was founded by William P. Murphy Jr. in 1959 and is headquartered in Milpitas, CA.

Sutura, Inc. develops invasive vascular suturing devices. The company also develops SuperStitch products which allow physicians to suture the arteriotomy or vascular tissue using fluoroscopic or ultrasonic. It was founded in 1996 and is headquartered in Fountain Valley, CA.

OrbusNeich Medical, Inc. is an American company that manufactures medical instruments. Alfred J. Novak has been the CEO of the private company since 1999.

Microvisk Ltd. engages in the manufacture and development of micro-viscometer based on micro electro mechanical sensors technology for medical field. The firm's products include CoagMax, CoagLite, CoagManager and SmartStrip. It develops technology for the detection and analysis of a fluid's properties using a cantilever-based micro-viscometer. The company was founded by Vladislav Djakov, Paul Morgan Vernon and Jeremy Burford Peckham in 2004 and is headquartered in Oxford, the United Kingdom.

Cultivation Capital LLC (Cultivation Capital) is a venture capital firm founded in 2012 by Brian Matthews, Cliff Holekamp, Jim McKelvey, Kyle Welborn, and Peter Esparrago. The firm is headquartered in St. Louis, Missouri.

Part of Abbott Laboratories, Abbott Laboratories Ltd. (Hong Kong) is a Chinese company that wholesales surgical and medical instruments. The company is based in Hong Kong, Hong Kong.

On AG manufactures and wholesales running shoes. The company was by David Allemann, Olivier Bernhard and Caspar Coppetti and is headquartered in Zürich, Switzerland.

M.A. Med Alliance SA is a company based in Nyon, Switzerland that specializes in developing innovative technology and commercializing advanced drug device combination products for the treatment of coronary and peripheral artery disease. The Swiss company's flagship product is the Selution SLR™ DEB, which is a novel sirolimus-eluting balloon platform technology. The CEO of the company is Jeffrey Bryan Jump.